Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial.
Erelel M, Kaskal M, Akbal-Dagistan O, Issever H, Dagistanli AS, Balkanci H, Oguz MS, Qarayeva A, Culha M, Erturk A, Basarir NS, Sahin G, Uresin AY, Araman AO, Medetalibeyoglu A, Tukek T, Oncul MO, Yildiz-Pekoz A. Erelel M, et al. Among authors: yildiz pekoz a. Pharmaceutics. 2021 Oct 22;13(11):1768. doi: 10.3390/pharmaceutics13111768. Pharmaceutics. 2021. PMID: 34834183 Free PMC article.
Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.
Akbal-Dagistan O, Sevim M, Sen LS, Basarir NS, Culha M, Erturk A, Fael H, Kaptan E, Sancar S, Mulazimoglu Durmusoglu L, Yegen BC, Yildiz-Pekoz A. Akbal-Dagistan O, et al. Among authors: yildiz pekoz a. Pharmaceutics. 2022 Nov 4;14(11):2375. doi: 10.3390/pharmaceutics14112375. Pharmaceutics. 2022. PMID: 36365193 Free PMC article.
Advances in Pulmonary Drug Delivery.
Yıldız-Peköz A, Ehrhardt C. Yıldız-Peköz A, et al. Pharmaceutics. 2020 Sep 23;12(10):911. doi: 10.3390/pharmaceutics12100911. Pharmaceutics. 2020. PMID: 32977672 Free PMC article.
Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis.
Yildiz Pekoz A, Akbal Dagistan O, Fael H, Culha M, Erturk A, Basarir NS, Sahin G, Serhatli M, Cakirca G, Tekin S, Sen LS, Sevim M, Mulazimoglu Durmusoglu L, Yegen BC. Yildiz Pekoz A, et al. Drug Deliv. 2022 Dec;29(1):2846-2854. doi: 10.1080/10717544.2022.2118398. Drug Deliv. 2022. PMID: 36062490 Free PMC article.
11 results